Abbott Laboratories | ABT.USX
United States - USD

Stock Exchange: NYSE

Symbol: ABT

Sector: Healthcare

Industry: Medical Devices

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Abbott Laboratories Stats

Previous close:Daily change:
108.79-0.42%
52-Week High:52-Week Low:
137.4981.97
Market Cap:Beta:
187.5 Billion0.59

Abbott Laboratories Key Financials

P/E Ratio:Revenues:Revenue Growth:Gross Margin:
35.058346.6 Billion13.00%56.85%
Dividend Yield:Net Income:Earnings Growth:Net Income Margin:
2.33%5.4 Billion-47.50%11.65%
P/E Ratio:Revenues:
35.058346.6 Billion
Dividend Yield:Net Income:
2.33%5.4 Billion
Revenue Growth:Gross Margin:
13.00%56.85%
Earnings Growth:Net Income Margin:
-47.50%11.65%
ParametersStocks Investing
Stock CurrencyUSD
Dividend PayingYes
Fractional SharesNo
Maximum Shares100 Shares
Tick value per 1 share0.01 USD
Trading Commission0%
Minimum Price Increment0.01
Limit and Stop Levels0.0
Negative balance protectionNo
Swap free days allowanceN/A
Own the underlying AssetNo
Platform symbolABT.USX
Disclaimer: 本資料は、情報提供のみを目的とした一般的なマーケティング・コミュニケーションとして第三者のデータソースから提供されたものであり、独立した投資調査を構成するものではありません。本資料には、投資助言、投資推奨、または金融商品の売買を目的とした勧誘は一切含まれておらず、また含まれているとみなされるべきでもありません。提供されるすべての情報は、信頼できる情報源から収集されたものであり、過去のパフォーマンスを示す情報は、将来のパフォーマンスを保証するものでも、信頼できる指標でもありません。利用者は、CFDおよび株式現物商品への投資は、一定の不確実性を特徴とするものであり、このような性質の投資は、利用者が単独で責任と義務を負う高度のリスクを伴うものであることを認識するものとします。当社は、ここに提示された情報に基づいて行われた投資によって生じたいかなる損失に対しても責任を負いません。